Recite me link

1. Within your trust how many trained and active staff do you have that can administer the anti-VEGF injection [Ranibizumab, Bevacizumab or Aflibercept]?
2. Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between September to December 2019
If your trust is able to identify injections/implants by eye conditions please split by the drug used [Ranibizumab, bevacizumab, Aflibercept, Fluocinolone and Dexamethasone],
If you are unable to split by condition then please just indicate the number of times a drug has been used (regardless of condition)

Download response Ophthalmology injectors. 020320